← Insider buys
RETA

Reata Pharmaceuticals Inc

Director James Edward Bass sold $587K of Reata Pharmaceuticals Inc

Sold$586,920
$100.29Price
5,852Shares
−5%Stake

What RETA did after the filing

Prices for RETA after this filing aren't in yet.

Traded Tue, Mar 5. Filed Thu, Mar 7, 12:05 PM ET, during the session. Not investment advice.